Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.
Parnax Lab financials and key ratios
Figures from the company's filings with NSE
Parnax Lab (NSE: PARNAXLAB) — financials from its filings with NSE.
Parnax Lab at a glance · consolidated
Free cash flow (FY25)
₹28 lakh
EPS (FY25)
₹1.21
Questions
What is the Parnax Lab EPS?
Parnax Lab's basic earnings per share (EPS) were ₹1.21 in FY25.
What is the Parnax Lab free cash flow?
In FY25, Parnax Lab generated ₹28 lakh of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹28 lakh. In FY24 it was −₹3.7 lakh.
Where do these Parnax Lab figures come from?
From Parnax Lab's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
